Back

Discussant review - FOURIER-OLE .

29 August 2022 (09:16 - 09:21)
Organised by:
Congress Presentation Part of: HOT LINE SESSION 8 Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Ulrich Laufs

University Hospital Leipzig, Leipzig (Germany)

14 More presentations in this session

Presentation thumbnail
ISCHEMIA-CKD EXTEND - Clinical Outcomes at 5 years of Follow-up.
Professor S. Bangalore (New York, US)
Slides Video
Presentation thumbnail
Discussant review - ISCHEMIA-CKD EXTEND.
Professor D. Bhatt (New York City, US)
Slides Video
Presentation thumbnail
Panel discussion - ISCHEMIA-CKD EXTEND.
Video
Presentation thumbnail
15-month results of the MASTER DAPT trial.
Professor M. Valgimigli (Lugano, CH)
Slides Video
Presentation thumbnail
Discussant review - MASTER DAPT.
Professor S. Schuepke (Munich, DE)
Slides Video

Access the full session

Session thumbnail
HOT LINE SESSION 8
Video

The Event

Event poster

ESC Congress 2022

29 August 2022 09:16 CET
You may be interested in
thumbnail
Congress Presentation
What about long-term prevention?
30 August 2024
thumbnail
Congress Presentation
Evolocumab treatment is associated with early and sustained reductions in low-density cholesterol (LDL-C) over 30 months: final results from the pan-European observational HEYMANS registry
26 August 2022
thumbnail
Congress Presentation
Longer-term safety of alirocumab with 24,610 patient-years of placebo-controlled observation: Further insights from the ODYSSEY OUTCOMES trial
26 August 2022
thumbnail
Congress Session
Late-breaking science on pharmacology
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources